Global Sugar-Based Excipients Market is valued at approximately USD 1.05 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 4.3% over the forecast period 2022-2028. Excipients are the inactive constituents that are used in the process of formulation for supporting the active pharmaceutical constituents. The adoption of numerous types of sugars especially sucrose in large quantities is gaining huge traction across the pharmaceutical industry because it is an easy to process, cost-effective, bulking and good taste carrier ingredient. Sugar-Based Excipients are categorized as artificial sweeteners, actual sugar, and sugar alcohol. The growing adoption of the co-processed excipients, growing investments for the development of orally disintegrating tablets (ODTS), coupled with the growth of the pharmaceutical industry are the factors that may stimulate the market demand around the world. For instance, according to the IBEF, in 2020 the pharmaceutical sector in India ranked 3rd in terms of volume and 13th in terms of value globally with worth USD 42 billion and is anticipated to grow by 17.7% annually. However, stringent quality control procedures impede the growth of the market over the forecast period of 2022-2028. Also, shifting the focus of pharmaceutical manufacturing to emerging countries is anticipated to act as a catalyzing factor for the market demand during the forecast period.
The key regions considered for the Global Sugar-Based Excipients Market study include Asia Pacific, North America, Europe, Latin America, and the rest of the World. Europe is the leading region across the world in terms of market share owing to the increasing production of generic drugs, and rising investments in drug advancement. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the rising number of favorable government policies, as well as the exponential growth of the pharmaceutical industry would create lucrative growth prospects for the Sugar-Based Excipients Market across the Asia-Pacific region.
Major market players included in this report are:
Roquette Group
DFE Pharma
BASF SE
Ashland Inc.
Archer Daniels Midland Company
Associated British Foods Plc
Cargill, Inc.
Colorcon, Inc.
FMC Corporation
The Lubrizol Corporation
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Actual Sugars
Sugar Alcohols
Artificial Sweeteners
By Type:
Powders/granules
Direct Compression Sugars
Crystals
Syrups
By Functionality:
Fillers & Diluents
Flavoring Agents
Tonicity Agents
Other Functionalities
By Formulation:
Oral Formulations
Parenteral Formulations
Topical Formulations
Other Formulations
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Sugar-Based Excipients Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
